Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New Guideline Defines Optimal Post-Op Opioid Dosage

By HospiMedica International staff writers
Posted on 09 Oct 2017
A new study provides evidence-based guidelines for opioid pain prescription length, which balance pain management with risk of addiction.

Researchers at Brigham and Women’s Hospital (BWH; Boston, MA, USA) and the Uniformed Services University of the Health Sciences (USUHS; Bethesda, MD, USA) conducted a study involving 215,140 individuals (107,588 women and 107,552 men; 18 to 64 years of age) in order to clarify patterns of opioid pain medication prescriptions following eight common surgical procedures, and to determine appropriateness of the prescription as shown by need for an additional prescription for opioid pain medication, or a refill.

The results indicated that the median observed prescription lengths were four days for general surgery procedures, four days for women’s health procedures, and six days for musculoskeletal procedures. More...
The prescription lengths associated with lowest requirement for refill were nine days for general surgery, 13 days for women’s health, and 15 days for musculoskeletal procedures. The number of people who required a refill of their opiate prescription varied from 11.3-39.3%, depending on the type of procedure performed. The study was published in the September 2017 issue of JAMA.

“Ideally, opioid prescriptions after surgery should balance adequate pain management against the duration of treatment,” said lead author Rebecca Scully, MD, MPH, of BWH. “While seven days may be more than adequate for many patients undergoing common general surgery and gynecological procedures, prescription length limits may need to be extended to 10 days, recognizing that as many as 40% of patients may still require a refill at a seven-day limit for pain management, particularly following many orthopedic and neurosurgical procedures.”

Opioids are primarily used for pain relief, but are also used to suppress cough and diarrhea. They act by binding to opioid receptors found in the central and peripheral nervous system and the gastrointestinal (GI) tract. The receptors mediate both the psychoactive and the somatic effects of opioids. Side effects of opioids include itchiness, sedation, nausea, respiratory depression, constipation, and euphoria. Since opioid use can lead to addiction and fatal overdose, most are controlled substances.

Related Links:
Brigham and Women’s Hospital
Uniformed Services University of the Health Sciences


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.